Mexican Pharmaceutical Forum
Mexican Pharmaceutical Forum
  • Languages
  • Home
  • About us
  • Venue
  • Programme
  • Speakers
  • Suggest a speaker
  • Networking
  • Mexican Pharma Awards
    • About the Awards
    • Application for the nomination
  • Sponsorship
  • News
  • Contact us
  • Languages
  • Home
  • About us
  • Venue
  • Programme
  • Speakers
  • Suggest a speaker
  • Networking
  • Mexican Pharma Awards
    • About the Awards
    • Application for the nomination
  • Sponsorship
  • News
  • Contact us
MEXICO: +52 558 526-60-31
UK:
+44 204 577-36-57
mexico@iventu.co.uk
45 Fitzroy Street, Fitzrovia London, W1T 6EB, United Kingdom
Mexican Pharmaceutical Forum
Mexican Pharmaceutical Forum


Footer – Español

Continue Reading

Footer

Continue Reading


COFEPRIS warns about counterfeit drugs against cancer and types 2 diabetes

0August 22, 20220

The advances in the pharmaceutical industry in Mexico stand out

0October 3, 20220

COFEPRIS attends 219 technical sessions for the pharmaceutical sector

0August 10, 20220

Avanza reforma para facilitar acceso a naloxona como tratamiento contra sobredosis de opioides

0July 19, 20220

México y Corea impulsarán el tratado de libre comercio entre ambos países. Empresas farmacéuticas coreanas muestran interés en el mercado mexicano

0July 6, 20220

AMELAF AMELAF AMLO AMLO Bayer Bayer Becton Dickinson Becton Dickinson CANIFARMA CANIFARMA Cannabis Cannabis COFEPRIS COFEPRIS Concamin Concamin counterfeit drugs COVAX COVID-19 COVID-19 Edomex Edomex Estados Unidos falsificación de medicamentos INEGI INEGI INSABI INSABI Latin America Latinoamérica Monkeypox Neolpharma Neolpharma Novartis Novartis Mexico SFP T-MEC UNEFARM UNEFARM UNOPS UNOPS US Vaccines Vacunas Viruela del mono

Global Pharmaceutical Leaders' Club

45 Fitzroy Street, Fitzrovia
London, W1T 6EB, United Kingdom

MEXICO +52 558 526-60-31
UK+44 204 577-36-57
Send your inquiry

© 2024 Global Pharmaceutical Leaders' Club Ltd. All rights reserved | Privacy Policy | Terms and Conditions | FAQ